Strongbridge Biopharma PLC Research and Development Expenses 2016-2021 | SBBP
Strongbridge Biopharma PLC research and development expenses from 2016 to 2021. Research and development expenses can be defined as an expense arising from studies and product development processes.
| Strongbridge Biopharma PLC Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2020 | $26 |
| 2019 | $31 |
| 2018 | $25 |
| 2017 | $17 |
| 2016 | $20 |
| 2015 | $20 |
| 2014 | $6 |
| 2013 | $3 |
| Strongbridge Biopharma PLC Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2021-06-30 | $5 |
| 2021-03-31 | $6 |
| 2020-12-31 | $12 |
| 2020-09-30 | |
| 2020-06-30 | $6 |
| 2020-03-31 | $8 |
| 2019-12-31 | $16 |
| 2019-09-30 | |
| 2019-06-30 | $9 |
| 2019-03-31 | $7 |
| 2018-12-31 | $8 |
| 2018-09-30 | $7 |
| 2018-06-30 | $5 |
| 2018-03-31 | $5 |
| 2017-12-31 | $5 |
| 2017-09-30 | $5 |
| 2017-06-30 | $4 |
| 2017-03-31 | $3 |
| 2016-12-31 | $4 |
| 2016-09-30 | $5 |
| 2016-06-30 | $5 |
| 2016-03-31 | $7 |
| 2015-12-31 | $6 |
| 2015-09-30 | $4 |
| 2015-06-30 | $8 |
| 2015-03-31 | $3 |
